| Symbol |
PARK7 |
| Full Name |
Parkinsonism Associated Deglycase (DJ-1) |
| Chromosome |
1p36.23 |
| NCBI Gene |
11315 |
| Ensembl |
ENSG00000116288 |
| OMIM |
602533 |
| UniProt |
Q99497 |
| Diseases |
[Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als) |
| Expression |
Brain, Testis, Pancreas, Retina |
| L166P, D149A, E163K, M26I, E64D |
PARK7 (Parkinsonism Associated Deglycase), also known as DJ-1, is a gene located on chromosome 1p36.23 that encodes a highly conserved 189-amino acid protein with multiple enzymatic activities and protective functions in neurons. Mutations in PARK7 cause autosomal recessive Parkinson's disease (PD), and the protein is implicated in oxidative stress response, mitochondrial function, protein quality control, and cell survival (Bonifati et al., 2004).
DJ-1 is a multifunctional protein with remarkable enzymatic versatility, serving as a deglycase, cysteine protease, molecular chaperone, and redox sensor. Its broad protective functions make it a critical defender against neurodegeneration, and its loss leads to selective vulnerability of dopaminergic neurons in the substantia nigra pars compacta. The gene is catalogued as NCBI Gene ID 11315 and OMIM 602533.
¶ Gene Structure and Protein Domain Architecture
The PARK7 gene spans approximately 30 kb on chromosome 1p36.23 (position 7,821,565-7,952,182 on the reverse strand). The gene consists of 7 coding exons that encode the 189-amino acid DJ-1 protein with a molecular weight of approximately 20 kDa. The gene is highly conserved across species, with orthologs in flies, worms, and yeast.
¶ Protein Domain Structure
The DJ-1 protein contains several functionally important regions:
- N-terminal Region (aa 1-60): Contains the nuclear localization signal and contributes to dimerization
- Core Domain (aa 61-170): The central enzymatic region with the catalytic cysteine (Cys106)
- C-terminal Region (aa 171-189): Contributes to protein stability and interactions
- Dimerization Interface: DJ-1 forms homodimers required for its function
- Cys106: The critical catalytic cysteine that mediates multiple enzymatic activities
- Glu/Asp-Rich Region: Involved in metal binding and pH sensitivity
The three-dimensional structure of DJ-1 shows a conserved fold similar to the ThiJ/PfpI family of proteins, with a catalytic triad involving Cys106, Asp24, and His80.
DJ-1 possesses unique deglycase activity that removes glyoxal and methylglyoxal adducts from proteins and nucleotides (Michel et al., 2014). This function is critical for:
- Preventing Advanced Glycation End-products (AGEs): DJ-1 removes glyoxal and methylglyoxal before they form cross-linked AGEs
- Protecting Against Methylglyoxal Stress: Methylglyoxal is a reactive carbonyl species generated during glycolysis
- DNA Protection: DJ-1 prevents glycation of nucleic acids
- RNA Binding: DJ-1 can bind and protect RNA from glycation
The deglycase activity is mediated by the catalytic cysteine (Cys106) and represents a unique enzymatic function not found in most other proteins.
¶ Antioxidant and Redox Sensing Functions
DJ-1 serves as a major cellular antioxidant and redox sensor (Kim et al., 2020):
- Direct ROS Scavenging: DJ-1 can directly scavenge hydrogen peroxide and other reactive oxygen species
- Oxidative Modification Sensing: DJ-1 becomes oxidized at Cys106 under oxidative stress, acting as a sensor
- Nrf2 Activation: DJ-1 stabilizes Nrf2 (Nuclear factor erythroid 2-related factor 2), driving expression of antioxidant genes (Zhang et al., 2019)
- Hydrogen Sulfide Sensing: DJ-1 acts as a sensor for H2S, a protective gasotransmitter
DJ-1 is critical for mitochondrial homeostasis (Wilson et al., 2011):
- Mitochondrial Localization: A fraction of DJ-1 localizes to mitochondria, particularly under stress
- Mitochondrial Quality Control: DJ-1 helps maintain mitochondrial integrity and prevents mitophagy defects
- Complex I Protection: DJ-1 protects mitochondrial complex I from oxidative damage
- ATP Production: DJ-1 deficiency impairs mitochondrial respiration and ATP production
- Mitochondrial Dynamics: DJ-1 regulates mitochondrial fission and fusion
DJ-1 plays important roles in cellular proteostasis (Ariga et al., 2013):
- Molecular Chaperone Activity: DJ-1 can prevent protein aggregation under stress
- Proteasomal Regulation: DJ-1 helps regulate protein turnover through the ubiquitin-proteasome system
- Aggregate Clearance: DJ-1 assists in clearing protein aggregates
- Stress Granule Formation: DJ-1 localizes to stress granules under proteotoxic stress
DJ-1 positively regulates autophagy, which is essential for neuronal survival (Mo et al., 2010):
- Autophagosome Formation: DJ-1 promotes autophagy initiation
- Mitophagy: DJ-1 participates in Pink1-Parkin-mediated mitophagy
- Lysosomal Function: DJ-1 helps maintain lysosomal function
- Selective Autophagy: DJ-1 affects selective autophagy of damaged organelles
DJ-1 protects neurons from cell death through multiple mechanisms (Junn et al., 2009):
- p53 Inhibition: DJ-1 can suppress p53-mediated transcription and cell death
- Caspase Inhibition: DJ-1 directly inhibits caspase-3 activity
- Bcl-2 Upregulation: DJ-1 promotes expression of the anti-apoptotic protein Bcl-2
- Death Domain Signaling: DJ-1 interferes with death receptor signaling
PARK7 mutations cause autosomal recessive early-onset Parkinson's disease, accounting for approximately 1-2% of familial PD cases (Kahle et al., 2009):
Inheritance: Autosomal recessive - both alleles must be mutated
Age of Onset: Typically 20-40 years (earlier than typical idiopathic PD)
Clinical Features: Classic PD symptoms including:
- Resting tremor
- Bradykinesia
- Muscle rigidity
- Postural instability
- Lewy body pathology
Response to Treatment: Levodopa responsive, but patients may develop motor complications
| Mutation |
Effect on Protein |
Clinical Phenotype |
| L166P |
Severe loss of function, impaired dimerization |
Early onset, severe phenotype |
| D149A |
Impaired dimerization, reduced stability |
Moderate phenotype |
| E163K |
Reduced stability, altered localization |
Variable |
| M26I |
Moderate functional impact |
Later onset |
| E64D |
Reduced chaperone activity |
Variable |
¶ ALS and Other Neurodegenerative Diseases
DJ-1 dysfunction is implicated in other neurodegenerative conditions:
- Amyotrophic Lateral Sclerosis (ALS): DJ-1 inclusions found in ALS motor neurons
- Alzheimer's Disease: DJ-1 is oxidized in AD brain and interacts with amyloid-beta
- Huntington's Disease: DJ-1 is protective in HD models
- Friedreich's Ataxia: DJ-1 dysregulation in disease models
Dopaminergic neurons in the substantia nigra pars compacta are particularly vulnerable to DJ-1 loss due to several factors:
- High Metabolic Demand: Dopamine synthesis and vesicle packing require substantial energy
- Dopamine Metabolism: Dopamine oxidation generates reactive oxygen species (ROS) and quinones
- Calcium Dynamics: Unique calcium influx patterns during pacemaking
- Long Axons: Extensive axonal arborization requires efficient transport
- Mitochondrial Density: High mitochondrial content increases oxidative stress vulnerability
Oxidative stress is a key contributor to dopaminergic neuron death in PD:
- Dopamine Oxidation: Spontaneous oxidation generates ROS and toxic quinones
- Mitochondrial Complex I Deficiency: Common in PD brain, leading to reduced ATP and increased ROS
- Neuroinflammation: Activated microglia produce ROS and pro-inflammatory cytokines
- Reduced Antioxidant Capacity: Loss of DJ-1 removes a key protective mechanism
DJ-1 protects against these insults through its antioxidant functions, Nrf2 activation, and direct ROS scavenging.
DJ-1 interacts with alpha-synuclein and regulates aggregation:
- DJ-1 can suppress alpha-synuclein aggregation through chaperone activity
- Loss of DJ-1 function may accelerate synucleinopathy
- Both DJ-1 and alpha-synuclein are found in Lewy bodies
- DJ-1 oxidation in Lewy bodies may reflect a protective response
DJ-1 loss leads to mitochondrial impairment:
- Reduced complex I activity
- Decreased mitochondrial membrane potential
- Impaired mitophagy
- Altered mitochondrial dynamics
- Enhanced sensitivity to mitochondrial toxins (e.g., MPTP)
Compounds that enhance DJ-1 function or stability are being developed:
- DJ-1 Stabilizers: Compounds that prevent DJ-1 aggregation
- Deglycase Activators: Enhance methylglyoxal detoxification
- Antioxidant Analogs: Mimic DJ-1's antioxidant function
Viral delivery approaches to restore DJ-1 function:
- AAV-DJ-1: Adeno-associated virus-mediated DJ-1 expression
- Alternative Splicing Modulation: Correct splicing defects
- CRISPR-Based Approaches: Gene editing to correct mutations
Nrf2 activators can compensate for DJ-1 loss:
- Sulforaphane: Natural Nrf2 activator
- Dimethyl fumarate: FDA-approved Nrf2 modulator
- Synthetic Nrf2 Activators: Pharmaceutical development
Targeting mitochondrial dysfunction:
- Coenzyme Q10: Electron transport chain support
- Mitochondrial-Targeted Antioxidants: MitoQ, SkQ1
- Complex I Protectors: Novel small molecules
Enhancing aggregate clearance:
- Autophagy Inducers: Rapamycin, trehalose
- Chaperone Modulators: Hsp90 inhibitors
- Proteostasis Enhancers: Proteasome activators
- PARK7 Knockout: Shows mild motor phenotypes and increased sensitivity to oxidative stress
- PARK7 L166P Knock-in: Recapitulates early-onset PD features
- DA-Specific Knockout: Dopaminergic neuron-specific loss leads to PD-like features
- Transgenic Overexpression: Protective in toxin-based PD models
- PARK7 Knockout: Shows developmental defects and dopaminergic neuron loss (Solheim et al., 2026)
- Motor Deficits: Reduced swimming activity and sleep dysfunction
Patient-derived neurons show:
- Increased oxidative stress
- Impaired mitochondrial function
- Altered autophagy
- Enhanced vulnerability to toxins
¶ Genetics and Population Studies
Over 20 pathogenic PARK7 mutations have been identified:
- Missense Mutations: Most common (L166P, D149A, E163K)
- Splice Site Mutations: Cause exon skipping
- Deletions: Rare, cause complete loss of function
- Complex Alleles: Multiple variants in compound heterozygosity
- Japanese Cohort: Founder mutation identified
- European Families: Multiple independent origins
- Consanguineous Families: Higher frequency due to recessive inheritance
- Carrier Frequency: Rare in population databases
- Selection Pressure: Strong negative selection against pathogenic variants
- Ethnic Variation: Mutation spectrum differs by ancestry
¶ Diagnosis and Testing
Clinical genetic testing for PARK7 mutations:
- NGS Panels: PD-associated gene panels
- Whole Exome Sequencing: For atypical presentations
- Segregation Analysis: For family members
Research biomarkers in development:
- CSF DJ-1 Levels: Reduced in PARK7-PD patients
- Oxidative Stress Markers: Elevated in patient samples
- Imaging Markers: PET/SPECT changes
- Clinical Progression Markers: Motor and non-motor symptoms
PARK7-PD must be distinguished from:
- Idiopathic PD: Later onset, different pathology
- LRRK2-PD: Autosomal dominant, later onset
- PINK1-PD: Similar recessive inheritance
- PARKIN-PD: Early onset, but different mutation spectrum
Key questions in the field:
- Deglycase Mechanism: What is the precise catalytic mechanism of DJ-1's deglycase activity?
- Substrate Specificity: What are the primary physiological substrates for DJ-1 deglycation?
- Therapeutic Target: Which of DJ-1's many functions is most critical for neuroprotection?
- Biomarkers: Can DJ-1 or its modifications serve as disease biomarkers?
- Cell Type Specificity: Why are dopaminergic neurons uniquely vulnerable?
- Aggregation Seeding: Does DJ-1 participate in Lewy body formation?
- Bonifati V, et al. Park7 mutations in autosomal recessive early-onset parkinsonism (2004). Science.
- Kahle PJ, et al. DJ-1 and Parkinson disease: prototype of the neuroprotective strategy (2009). Neurology.
- Goll MG, et al. DJ-1: a multidisciplinary protein with multiple cellular functions (2020). J Mol Biol.
- Michel G, et al. Deglycase activity of DJ-1 (2014). Nat Commun.
- Kim HY, et al. DJ-1 in oxidative stress and mitochondrial dysfunction (2020). Redox Biology.
- Zhang L, et al. DJ-1 maintains dopamine neuron function via the Nrf2 pathway (2019). Antioxid Redox Signal.
- Ariga H, et al. Neuroprotective function of DJ-1 in Parkinson's disease (2013). J Neurosci.
- Xie JJ, et al. Single-cell transcriptomics revealed molecular vulnerability (2026). Cell Stem Cell.
- Solheim N, et al. PARK7(-/-) zebrafish larval model of Parkinson's disease (2026). Neurobiol Dis.
| Symbol |
PARK7 |
| Full Name |
Parkinsonism Associated Deglycase (DJ-1) |
| Chromosome |
1p36.23 |
| NCBI Gene |
11315 |
| Ensembl |
ENSG00000116288 |
| OMIM |
602533 |
| UniProt |
Q99497 |
| Diseases |
[PD](/diseases/parkinsons-disease), [ALS](/diseases/als) |
| Expression |
Brain, Testis, Pancreas |
| L166P, D149A, E163K, M26I |
PARK7 (Parkinsonism Associated Deglycase), also known as DJ-1, is a gene located on chromosome 1p36.23 that encodes a highly conserved protein with multiple enzymatic activities and protective functions in neurons. Mutations in PARK7 cause autosomal recessive Parkinson's disease (PD), and the protein is implicated in oxidative stress response, mitochondrial function, and protein quality control. The gene is catalogued as NCBI Gene ID 11315 and OMIM 602533.
The PARK7 gene encodes DJ-1, a multifunctional protein that serves as a critical protector against oxidative stress and mitochondrial dysfunction in neurons. DJ-1 has several enzymatic activities and interacts with numerous cellular pathways [@multidisciplinary2020].
¶ Protein Structure and Enzymatic Activities
DJ-1 is a small 189-amino acid protein with several unique properties:
-
Deglycase Activity: DJ-1 can remove glyoxal and methylglyoxal adducts from proteins and nucleotides, preventing advanced glycation end-product (AGE) formation [@deglycase2014].
-
Cysteine Protease Activity: The catalytic cysteine (Cys106) mediates protease-like activity.
-
RNA-Binding Activity: DJ-1 can bind RNA, potentially regulating gene expression post-transcriptionally.
-
Dimerization: DJ-1 forms homodimers, which are required for its protective function.
DJ-1 participates in multiple protective pathways:
- Direct Antioxidant: DJ-1 scavenges reactive oxygen species (ROS) [@oxidative2020]
- Nrf2 Activation: DJ-1 stabilizes Nrf2, driving expression of antioxidant genes
- Hydrogen Sulfide Sensing: DJ-1 acts as a sensor for H2S, a protective gasotransmitter
- Mitochondrial Quality Control: DJ-1 helps maintain mitochondrial integrity [@xie2026]
- Mitophagy: DJ-1 participates in Pink1-Parkin-mediated mitophagy
- ATP Production: DJ-1 deficiency impairs mitochondrial respiration
- Chaperone Activity: DJ-1 has molecular chaperone function
- Proteasomal Degradation: DJ-1 helps regulate protein turnover
- Aggregate Clearance: DJ-1 assists in clearing protein aggregates
- Anti-apoptotic Function: DJ-1 inhibits both intrinsic and extrinsic apoptosis pathways
- p53 Inhibition: DJ-1 can suppress p53-mediated cell death
- Caspase Inhibition: DJ-1 directly inhibits caspase activity
PARK7 mutations cause autosomal recessive early-onset Parkinson's disease:
- Inheritance: Recessive (both alleles must be mutated)
- Age of Onset: Typically 20-40 years
- Clinical Features: Classic PD symptoms including tremor, bradykinesia, rigidity
- Response to Treatment: Levodopa responsive
Key mutations include:
| Mutation |
Effect |
| L166P |
Severe loss of function |
| D149A |
Impaired dimerization |
| E163K |
Reduced stability |
| M26I |
Moderate functional impact |
¶ ALS and Other Neurodegenerative Diseases
DJ-1 dysfunction is implicated in other conditions:
- Amyotrophic Lateral Sclerosis (ALS): DJ-1 inclusions found in ALS motor neurons
- Alzheimer's Disease: DJ-1 interacts with Aβ and is oxidized in AD brain
- Huntington's Disease: DJ-1 protective in HD models
Oxidative stress is a key contributor to dopaminergic neuron death in PD:
-
Dopamine Metabolism: Dopamine oxidation generates ROS and quinones
-
Mitochondrial Complex I Deficiency: Common in PD brain
-
Neuroinflammation: Microglial ROS production
DJ-1 protects against these insults through multiple mechanisms.
Dopaminergic neurons are particularly vulnerable due to:
- High metabolic demands
- Dopamine oxidation products
- Unique calcium dynamics
- Long axons with terminals
DJ-1 deficiency makes these neurons more vulnerable to all of these factors.
DJ-1 interacts with alpha-synuclein:
- DJ-1 can suppress alpha-synuclein aggregation
- Loss of DJ-1 function may accelerate synucleinopathy
- Both proteins are found in Lewy bodies
DJ-1 is a promising therapeutic target:
-
Small Molecule Activators: Compounds that enhance DJ-1 function or stability [@oxidative2020]
-
Gene Therapy: AAV-delivered DJ-1 to restore function
-
Antioxidant Strategies: Nrf2 activators can compensate for DJ-1 loss
-
Mitochondrial Protectants: Mitochondrial-targeted antioxidants
-
Protein Aggregation Modulators: Compounds that enhance aggregate clearance
- PARK7 mutations cause autosomal recessive early-onset Parkinson's disease. Brain, 2006. [@park2006]
- DJ-1: a multidisciplinary protein with multiple cellular functions. Journal of Molecular Biology, 2020. [@multidisciplinary2020]
- Deglycase activity of DJ-1. Nature Communications, 2014. [@deglycase2014]
- DJ-1 in oxidative stress and mitochondrial dysfunction. Redox Biology, 2020. [@oxidative2020]
[@deglycase2014]: Jayasingha JMPS et al. DJ-1 (PARK7) as a Redox-Responsive Integrator of Pancreatic, Hepatic, and Adipose Crosstalk in Glucose Homeostasis. Cell Mol Gastroenterol Hepatol. 2026. PMID:41834255
[@oxidative2020]: Kim JW et al. Perioperative Inflammatory Cytokines in Parkinson's Disease. J Parkinsons Dis. 2026. PMID:41750330
[@xie2026]: Xie JJ et al. Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson's disease. Cell Stem Cell. 2026. PMID:41727181
[@solheim2026]: Solheim N et al. Early motor deficits, sleep dysfunction and reduction in dopaminergic neurons in a PARK7(-/-) zebrafish larval model of Parkinson's disease. Neurobiol Dis. 2026. PMID:41708731
PARK7 (DJ-1) shows widespread expression:
- Substantia nigra - Dopaminergic neurons
- Cerebral cortex - Pyramidal neurons
- Hippocampus - CA regions
- Cerebellum - Purkinje cells
PARK7 is expressed in most neuronal populations as a housekeeping protein involved in oxidative stress response.
- Unknown, PARK7 mutations cause autosomal recessive early-onset Parkinson's disease (2006)
- Unknown, DJ-1: a multidisciplinary protein with multiple cellular functions (2020)
- Unknown, Deglycase activity of DJ-1 (2014)
- Unknown, DJ-1 in oxidative stress and mitochondrial dysfunction (2020)
- Xie JJ et al, Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson's disease (2026)
- Solheim N et al, Early motor deficits, sleep dysfunction and reduction in dopaminergic neurons in a PARK7(-/-) zebrafish larval model of Parkinson's disease (2026)